Development of acromegaly in patients with prolactinomas
- PMID: 12824861
- DOI: 10.1530/eje.0.1490017
Development of acromegaly in patients with prolactinomas
Abstract
Objectives: Patients with prolactinomas and patients with acromegaly often have heterogenous adenomas. In this study we have focused on patients with prolactinomas who developed acromegaly and acromegalic patients with hyperprolactinaemia. Our hypothesis is that some patients with hyperprolactinaemia may develop clinical acromegaly.
Methods: We have included patients examined at department M, Odense University Hospital between 1996 and 2001. Seventy-eight patients with prolactinomas, 65 females and 13 males, with a median age (range) of 30 Years (14-74) and 47 Years (20-66), respectively, were included in the study.
Results: In females and males the median prolactin (PRL) levels were 90 microg/l (27-4700; normal values (NV) <or=23) and 1075 microg/l (24-6500; NV <or=14), respectively. The PRL levels were significantly higher in males compared with females (P<0.002). Fifty-nine patients with acromegaly, 24 females and 35 males, with a median age (range) of 45 Years (24-70) and 53 Years (19-70), respectively, were included. Seven of the 24 females had hyperprolactinaemia, with PRL levels of 90 microg/l (27-494). Thirteen of the 35 males had hyperprolactinaemia with PRL levels of 47 microg/l (17-251). Three females with prolactinomas developed acromegaly clinically and biochemically. These patients had a normal low GH level and/or a normal IGF-I level at first diagnosis.
Conclusions: Our findings suggest that there is a common group of patients with a pituitary adenoma who secrete PRL and GH unsynchronously. Some of these patients have clinical acromegaly at diagnosis and some patients diagnosed as prolactinomas will develop acromegaly. We suggest an annual IGF-I measurement as a screening test.
Similar articles
-
Pituitary Tumors in Pregnancy.Endocrinol Metab Clin North Am. 2019 Sep;48(3):569-581. doi: 10.1016/j.ecl.2019.05.004. Epub 2019 Jun 13. Endocrinol Metab Clin North Am. 2019. PMID: 31345524 Review.
-
The higher incidence of autoimmune thyroid disease in prolactinomas than in somatotrophinomas.Growth Horm IGF Res. 2016 Aug;29:45-49. doi: 10.1016/j.ghir.2016.04.004. Epub 2016 Apr 11. Growth Horm IGF Res. 2016. PMID: 27105040
-
The characteristics of acromegalic patients with hyperprolactinemia and the differences in patients with merely GH-secreting adenomas: clinical analysis of 279 cases.Eur J Endocrinol. 2012 May;166(5):797-802. doi: 10.1530/EJE-11-1119. Epub 2012 Feb 14. Eur J Endocrinol. 2012. PMID: 22334636
-
PRL secreting adenomas in male patients.Pituitary. 2005;8(1):39-42. doi: 10.1007/s11102-005-5084-3. Pituitary. 2005. PMID: 16411067 Review.
-
Diagnosis, treatment, and outcome of pituitary tumors and other abnormal intrasellar masses. Retrospective analysis of 353 patients.Medicine (Baltimore). 1999 Jul;78(4):236-69. doi: 10.1097/00005792-199907000-00004. Medicine (Baltimore). 1999. PMID: 10424206
Cited by
-
[Acromegaly screening in patients with hyperprolactinemia and pituitary adenoma].Probl Endokrinol (Mosk). 2023 Sep 18;70(2):4-10. doi: 10.14341/probl13344. Probl Endokrinol (Mosk). 2023. PMID: 38796756 Free PMC article. Russian.
-
Prolactin and Growth Hormone Signaling and Interlink Focused on the Mammosomatotroph Paradigm: A Comprehensive Review of the Literature.Int J Mol Sci. 2023 Sep 12;24(18):14002. doi: 10.3390/ijms241814002. Int J Mol Sci. 2023. PMID: 37762304 Free PMC article. Review.
-
[Acromegaly in the differential diagnosis of hearing loss].Probl Endokrinol (Mosk). 2023 May 11;69(2):31-37. doi: 10.14341/probl13249. Probl Endokrinol (Mosk). 2023. PMID: 37448269 Free PMC article. Russian.
-
Long-term IGF-1 monitoring in prolactinoma patients treated with cabergoline might not be indicated.Endocrine. 2021 Apr;72(1):216-222. doi: 10.1007/s12020-020-02557-1. Epub 2020 Dec 4. Endocrine. 2021. PMID: 33275185
-
Effects of cabergoline therapy on serum IGF-1 concentrations in prolactinoma patients.Pituitary. 2020 Apr;23(2):200-202. doi: 10.1007/s11102-019-01011-4. Pituitary. 2020. PMID: 31760592 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical